Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00472186 · ClinicalTrials.gov registry record · Phase 4

The Effects of Reducing Stomach Acid on Post-tonsillectomy Pain

A Phase 4 study, sponsored by Boston Children's Hospital.

Terminated
Registry status
Phase 4
Development phase
2
Enrollment target

NCT00472186 is a Phase 4 study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00472186, a Phase 4 study, was terminated before completion, sponsored by Boston Children's Hospital.

TERMINATED
Registry status
Phase 4
Development phase
2 participants
Enrollment target

Study Summary

This study was designed to determine whether post-operative pain following a tonsillectomy can be reduced by adding an antacid-like medication to the medications taken after surgery. It is hypothesized that even a small amount of stomach acid backing up and entering the mouth can increase post-tonsillectomy pain. Therefore, the use of an antacid-like medication should help to decrease pain and reduce the amount of narcotic medication required for pain control.

Interventions

  • DRUG Placebo
  • DRUG Lansoprazole

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2008-06
Est. Completion 2011-02
Phase Phase 4

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00472186

The ClinicalTrials.gov registry entry for NCT00472186 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT00472186 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00472186 about?

NCT00472186 is a clinical study titled "The Effects of Reducing Stomach Acid on Post-tonsillectomy Pain". This study was designed to determine whether post-operative pain following a tonsillectomy can be reduced by adding an antacid-like medication to the medications taken after surgery. It is hypothesized that even a small amount of stomach acid backing up and entering the mouth can increase post-tonsi...

What is the current status of trial NCT00472186?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2008-06. Estimated completion is 2011-02.

What interventions are being tested in trial NCT00472186?

The interventions under investigation include: Placebo (DRUG), Lansoprazole (DRUG).

Who is sponsoring clinical trial NCT00472186?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.